ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

Bush May Nominate Zerhouni For NIH Director

March 8, 2002

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

Quality Oncology Wins Pilot Contract For Cancer Management In Fla.

July 27, 2001

Three Fourths Of Pediatric Patients are Getting Best Treatment; NCI Goal: Reach all The Others

May 20, 1977

NCI Bypass Budget An Underutilized Document and Ignored By MB; Deserves Attention Of Congress

January 20, 1989